The DOI matches its Crossref record; 113 of the 116 references it cites were found in a registry or an index.
13. Older Adults: Standards of Medical Care in Diabetes—2022
Open accessAbstract
The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc22-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc22-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Considering the older age of participants and comorbid conditions reported, the mean HbA1c, GMI, TIR, and TBR results (8.0%, 7.6%, 56%, and 1.0% at 6 months, respectively) demonstrate close adherence to established glycemic targets (23, 24, 38).”
From Observed Glycemic and Psychosocial Benefits in the Prospective Bigfoot Unity Real World Study: A 6-Month Analysis (2025) · cites this paper as [23]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Low and very low glucose events occurred at a low rate (mean of ∼1.3 and 0.2 events per person per week in the sixth month, respectively) and were in keeping with time below range meeting established standards (23, 24, 38).”
From Observed Glycemic and Psychosocial Benefits in the Prospective Bigfoot Unity Real World Study: A 6-Month Analysis (2025) · cites this paper as [23]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Other parameters such as the mean percent time of sensor use and mean coefficient of variation (84% and 31% at 6 months, respectively) are also within established guidelines (23, 24, 38).”
From Observed Glycemic and Psychosocial Benefits in the Prospective Bigfoot Unity Real World Study: A 6-Month Analysis (2025) · cites this paper as [23]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The observed reduction in HbA1c did not compromise the population from meeting established hypoglycemia targets of < 4% and < 1% for percent time < 70 mg/dL (mean 1.0%) and < 54 mg/dL (mean 0.04%), respectively (22-24).”
From Observed Glycemic and Psychosocial Benefits in the Prospective Bigfoot Unity Real World Study: A 6-Month Analysis (2025) · cites this paper as [23]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment
Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53221.x · Cited by 25,553
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830
The American Psychological Association
Langfeld, H. S. (1919) · Science · doi:10.1126/science.49.1254.51 · Cited by 7,453
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Wiviott, S. D., Raz, I., Bonaca, M. P., Mosenzon, O., Kato, E. T., Cahn, A., Silverman, M. G., Zelniker, T. A., Kuder, J. F., Murphy, S. A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812389 · Cited by 6,382
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetes Care · doi:10.2337/dci18-0033 · Cited by 3,518
Treatment of hypertension in patients 80 years of age or older
Beckett, N. S., Peters, R., Fletcher, A. E., Staessen, J. A., Liu, L., Dumitrascu, D., Stoyanovsky, V., Antikainen, R. L., Nikitin, Y., Anderson, C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801369 · Cited by 3,092
Research works printed but not linked: 6
- Laiteerapong, 2018, Diabetes in older adults
- Laiteerapong, 2012, Classification of older adults who have diabetes by comorbid conditions, United States, 2005-2006, Prev Chronic Dis, 9, E100
- Ghezzi, 2013, Disease-modifying drugs in Alzheimer’s disease, Drug Des Devel Ther, 7, 1471
- Tomlin, 2016, The influence of cognition on self-management of type 2 diabetes in older people, Psychol Res Behav Manag, 9, 7
- Sinclair, 2013, IDF Global Guideline For Managing Older People With Type 2 Diabetes
- Zhang, 2018, Change in insurance status and cost-related medication non-adherence among older U.S. adults with diabetes from 2010 to 2014, J Health Med Econ, 4, 7
Cited by
Sorted by citations
Virani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001168 · Cited by 1,598
Virani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.04.003 · Cited by 596
Type 2 diabetes and cognitive dysfunction–towards effective management of both comorbidities
Srikanth, V., Sinclair, A. J., Hill-Briggs, F., Moran, C., & Biessels, G. J. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30118-2 · Cited by 465
Mone, P., Varzideh, F., Jankauskas, S. S., Pansini, A., Lombardi, A., Frullone, S., & Santulli, G. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.19586 · Cited by 231
Hanlon, P., Fauré, I., Corcoran, N., Butterly, E. W., Lewsey, J., McAllister, D., & Mair, F. S. (2020) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(20)30014-3 · Cited by 203
Understanding multifactorial brain changes in type 2 diabetes: a biomarker perspective
Biessels, G. J., Nobili, F. M., Teunissen, C. E., Simó, R., & Scheltens, P. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30139-3 · Cited by 195
Amanat, S., Ghahri, S., Dianatinasab, A., Fararouei, M., & Dianatinasab, M. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1792-1_6 · Cited by 188
Mone, P., Lombardi, A., Gambardella, J., Pansini, A., Macina, G., Morgante, M., Frullone, S., & Santulli, G. (2022) · Diabetes Care · doi:10.2337/dc21-2434 · Cited by 167
Wu, C.-Y., Iskander, C., Wang, C., Xiong, L. Y., Shah, B. R., Edwards, J. D., Kapral, M. K., Herrmann, N., Lanctôt, K. L., Masellis, M., et al. (2023) · Diabetes Care · doi:10.2337/dc22-1705 · Cited by 139
The Influence of Lifestyle and Treatment on Oxidative Stress and Inflammation in Diabetes
Wronka, M., Krzemińska, J., Młynarska, E., Rysz, J., & Franczyk, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415743 · Cited by 140
Deprescribing in older adults with polypharmacy
Hung, A., Kim, Y. H., & Pavon, J. M. (2024) · BMJ · doi:10.1136/bmj-2023-074892 · Cited by 127
Diet, exercise, and pharmacotherapy for sarcopenia in people with diabetes
Hashimoto, Y., Takahashi, F., Okamura, T., Hamaguchi, M., & Fukui, M. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155585 · Cited by 126
Cardiorenal protection of SGLT2 inhibitors—Perspectives from metabolic reprogramming
Gao, Y.-M., Feng, S., Wen, Y., Tang, T., Wang, B., & Liu, B. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104215 · Cited by 125
Diabetes in ageing: pathways for developing the evidence base for clinical guidance
Munshi, M. N., Meneilly, G. S., Rodríguez‐Mañas, L., Close, K. L., Conlin, P. R., Cukierman‐Yaffe, T., Forbes, A., Ganda, O. P., Kahn, C. R., Huang, E. S., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30230-8 · Cited by 107
Mendes, R., Martins, S. P. V., & Fernandes, L. P. N. S. (2019) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3894 · Cited by 101
Life’s Essential 8 and Risk of Stroke: A Prospective Community-Based Study
Wu, S., Wu, Z., Yu, D., Chen, S., Wang, A., Wang, A., & Gao, X. (2023) · Stroke · doi:10.1161/strokeaha.123.042525 · Cited by 97
Metas no tratamento do diabetes
de Almeida-Pititto, B., Rodrigues, M. L. D., de Moura, F. F., Lamounier, R. N., Vencio, S. A. C., Calliari, L. E., & Bertoluci, M. C. (2022) · Conectando Pessoas eBooks · doi:10.29327/557753.2022-3 · Cited by 99
Type 2 diabetes mellitus and cognitive function: understanding the connections
Dao, L., CHOI, S. E., & Freeby, M. (2022) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000783 · Cited by 82
Kutz, A., Kim, D. H., Wexler, D. J., Liu, J., Schneeweiß, S., Glynn, R. J., & Patorno, E. (2023) · Diabetes Care · doi:10.2337/dc23-0671 · Cited by 82
Tian, S., Jiang, J., Wang, J., Zhang, Z., Miao, Y., Ji, X., & Bi, Y. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3673 · Cited by 79
SGLT2-inhibitors are effective and safe in the elderly: the SOLD study
Lunati, M. E., Cimino, V., Gandolfi, A., Trevisan, M., Montefusco, L., Pastore, I., Pace, C., Betella, N., Favacchio, G., Bulgheroni, M., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106396 · Cited by 77
Lifestyle Intervention Strategy to Treat Diabetes in Older Adults: A Randomized Controlled Trial
Celli, A., Barnouin, Y., Jiang, B. C., Blevins, D., Colleluori, G., Mediwala, S. N., Armamento‐Villareal, R., Qualls, C., & Villareal, D. T. (2022) · Diabetes Care · doi:10.2337/dc22-0338 · Cited by 81
Elendu, C., Okah, M. J., Fiemotongha, K. J. D., Boluwatife, A. I., Bassey, B. N., Omeludike, E., & Obidigbo, B. T. (2023) · Medicine · doi:10.1097/md.0000000000035397 · Cited by 77
Hou, Y., Xiang, J., Wang, B., Duan, S., Song, R., Zhou, W., Tan, S., & He, B. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1263650 · Cited by 72
Forlenza, G. P., Carlson, A. L., Galindo, R. J., Kruger, D. F., Levy, C. J., McGill, J. B., Umpierrez, G., & Aleppo, G. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0206 · Cited by 70
Wu, Y., Xiong, T., Tan, X. W., & Chen, L. (2022) · BMC Medicine · doi:10.1186/s12916-022-02675-9 · Cited by 70
Prevalencia de diabetes, características epidemiológicas y complicaciones vasculares
Russo, M. P., Ratti, M. F. G., Burgos, M. A., Molaro, A. A., & Bonella, M. B. (2023) · Archivos de cardiología de México · doi:10.24875/acm.21000410 · Cited by 90
Goh, L. H., Siah, C. J. R., Tam, W., Tai, E. S., & Young, D. Y. L. (2022) · Systematic Reviews · doi:10.1186/s13643-022-02117-w · Cited by 74
arif, M., O’Donovan, M. R., Sezgin, D., Moloney, E., Rodríguez‐Laso, Á., Liew, A., & Ó’Caoimh, R. (2022) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2022.895313 · Cited by 59
Hyperglycemia and Physical Impairment in Frail Hypertensive Older Adults
Pansini, A., Lombardi, A., Morgante, M., Frullone, S., Marro, A., Rizzo, M., Martinelli, G., Boccalone, E., Luca, A. D., Santulli, G., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.831556 · Cited by 54
Sanz‐París, A., Matía-Martín, P., Martín-Palmero, Á., Gómez‐Candela, C., & Robles, M. C. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.02.036 · Cited by 54
Efficacy and safety profile of SGLT2 inhibitors in the elderly: how is the benefit/risk balance?
Scheen, A. J., & Bonnet, F. (2023) · Diabetes & Metabolism · doi:10.1016/j.diabet.2023.101419 · Cited by 51
Risk Factors and Cardiovascular Disease in the Elderly
Díez‐Villanueva, P., Jiménez-Méndez, C., Bonanad, C., García‐Blas, S., Pérez-Rivera, J.-Á., Miguel, G. A., García‐Pardo, H., Formiga, F., Camafort, M., Martínez‐Sellés, M., et al. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2306188 · Cited by 52
Heart failure and diabetes: Understanding the bidirectional relationship
Elendu, C., Amaechi, D. C., Elendu, T. C., Ashna, M., Ross-Comptis, J., Ansong, S. O., Egbunu, E. O., Okafor, G. C., Jingwa, K. A., Akintunde, A. A., et al. (2023) · Medicine · doi:10.1097/md.0000000000034906 · Cited by 51
Pratley, R. E., Cannon, C. P., Cherney, D. Z. I., Cosentino, F., McGuire, D. K., Essex, M. N., Lawrence, D., Jones, P. L., Liu, J., Adamsons, I. A., et al. (2023) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(23)00032-6 · Cited by 45
Metabolic Impact of Frailty Changes Diabetes Trajectory
Sinclair, A. J., & Abdelhafiz, A. H. (2023) · Metabolites · doi:10.3390/metabo13020295 · Cited by 46
Hammad, M. A., Sulaiman, S. A. S., Aziz, N. A., & Noor, D. A. M. (2019) · Journal of Research in Medical Sciences · doi:10.4103/jrms.jrms_100_18 · Cited by 41
Zhang, Y., Pan, X., Lu, Q., Wang, Y., Geng, T., Zhou, Y., Liao, L. M., Tu, Z., Chen, J., Xia, P., et al. (2023) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2022.08.012 · Cited by 41
A practical framework for early detection of diabetes using ensemble machine learning models
Saihood, Q., & Sonuç, E. (2023) · TURKISH JOURNAL OF ELECTRICAL ENGINEERING & COMPUTER SCIENCES · doi:10.55730/1300-0632.4013 · Cited by 43
Shiroma, K., Tanabe, H., Takiguchi, Y., Yamaguchi, M., Sato, M., Saito, H., Tanaka, K., Masuzaki, H., Kazama, J. J., & Shimabukuro, M. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1087471 · Cited by 40
Yi, T. W., Smyth, B. J., Tanna, G. L. D., Arnott, C. G., Cardoza, K. P., Kang, A., Pollock, C. A., Agarwal, R., Bakris, G. L., Charytan, D. M., et al. (2023) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2022.12.015 · Cited by 37
Guerci, B., Levrat‐Guillen, F., Vicaut, É., de Pouvourville, G., Detournay, B., Emery, C., & Riveline, J. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0034 · Cited by 37
Fung, E., Lui, L.-T., Huang, L., Cheng, K. F., Lau, G. H. W., Chung, Y. T., Ahmadabadi, B. N., Xie, S., Lee, J. S. W., Hui, E., et al. (2021) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(21)00251-8 · Cited by 36
Prevalence of diabetes, epidemiological characteristics and vascular complications
Russo, M. P., Ratti, M. F. G., Burgos, M. A., Molaro, A. A., & Bonella, M. B. (2023) · Archivos de cardiolog�a de M�xico (English ed Internet) · doi:10.24875/acme.m23000372 · Cited by 34
Prasad‐Reddy, L., Godina, A., Chetty, A. K., Close Concerns, S. F., & Isaacs, D. (2022) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2022.18.2.116 · Cited by 36
Orkaby, A. R., Callahan, K. E., Driver, J. A., Hudson, K., Clegg, A. P., & Pajewski, N. M. (2024) · Age and Ageing · doi:10.1093/ageing/afae025 · Cited by 33
Gastaldi, G., Lucchini, B., Thalmann, S., Alder, S., Laimer, M. W., Brändle, M., Wiesli, P., Lehmann, R., & Working group of the SGED/SSED (2023) · Swiss Medical Weekly · doi:10.57187/smw.2023.40060 · Cited by 33
Chronic Kidney Disease in the Older Adult Patient with Diabetes
Ravender, R., Roumelioti, M., Schmidt, D. W., Unruh, M. L., & Argyropoulos, C. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13020348 · Cited by 34
A Qualitative Study of Perspectives of Older Adults on Deintensifying Diabetes Medications
Pilla, S. J., Meza, K., Schoenborn, N. L., Boyd, C. M., Maruthur, N. M., & Chander, G. (2022) · Journal of General Internal Medicine · doi:10.1007/s11606-022-07828-3 · Cited by 34
SGLT2 Inhibitors and Safety in Older Patients
Pollack, R. M., & Cahn, A. (2022) · Heart Failure Clinics · doi:10.1016/j.hfc.2022.03.002 · Cited by 31
Koto, R., Nakajima, A., Miwa, T., & Sugimoto, K. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01421-5 · Cited by 30
Kiyosue, A., Dunn, J. P., Cui, X., Hickey, A., Hirase, T., Imaoka, T., & Heine, R. J. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14952 · Cited by 30
Severe hypoglycemia and falls in older adults with diabetes: The Diabetes & Aging Study
Moffet, H. H., Huang, E. S., Liu, J. Y., Parker, M. M., Lipska, K. J., Laiteerapong, N., Grant, R. W., Lee, A. K., & Karter, A. J. (2023) · Diabetes Epidemiology and Management · doi:10.1016/j.deman.2023.100162 · Cited by 29
Closed-loop systems: recent advancements and lived experiences
Kadiyala, N., Hovorka, R., & Boughton, C. K. (2024) · Expert Review of Medical Devices · doi:10.1080/17434440.2024.2406901 · Cited by 29
Deng, Z., Thompson, W., Korenvain, C., Lega, I. C., Farrell, B. J., Lochnan, H. A., & McCarthy, L. M. (2022) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2022.01.009 · Cited by 29
An Approach to the Management of Diabetes Mellitus in Cirrhosis: A Primer for the Hepatologist
Puri, P., & Kotwal, N. (2021) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2021.09.010 · Cited by 29
Glucagon: Its evolving role in the management of hypoglycemia
Isaacs, D. M., Clements, J. N., Turco, N., & Hartman, R. (2021) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2534 · Cited by 29
Pilla, S. J., Jalalzai, R., Tang, O., Schoenborn, N. L., Boyd, C. M., Golden, S. H., Mathioudakis, N. N., & Maruthur, N. M. (2023) · Diabetes Care · doi:10.2337/dc22-2146 · Cited by 28
Virgilio, E., Trevisan, C., Abbatecola, A. M., Malara, A., Palmieri, A., Fedele, G., Stefanelli, P., Leone, P., Schiavoni, I., Maggi, S., et al. (2022) · Diabetes Care · doi:10.2337/dc22-1255 · Cited by 27
Abdallah, S. M. A., Ayoub, A. I., Makhlouf, M., & Ashour, A. (2024) · BMC Public Health · doi:10.1186/s12889-024-20238-w · Cited by 25
Christiaens, A., Henrard, S., SINCLAIR, A. J., Tubach, F., Bonnet‐Zamponi, D., & Zerah, L. (2023) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2022.12.018 · Cited by 24
Geriatric Syndromes in Older Adults with Diabetes
Neumiller, J. J., & Munshi, M. N. (2023) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2022.10.004 · Cited by 22
Toschi, E. (2023) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2022.10.006 · Cited by 23
Abdelhafiz, A. H., & SINCLAIR, A. J. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108144 · Cited by 22
Jang, G. Y., Chang, S. J., & Noh, J. H. (2024) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s448056 · Cited by 21
Severe Hypoglycemia Attributable to Intensive Glucose-Lowering Therapy Among US Adults With Diabetes
Mahoney, G. K., Henk, H. J., & McCoy, R. G. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.02.028 · Cited by 21
Kahkoska, A. R., Smith, C., Thambuluru, S. R., Weinstein, J., Batsis, J. A., Pratley, R. E., Weinstock, R. S., Young, L., & Lich, K. H. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110204 · Cited by 21
Grammes, J., Schmid, S., Bozkurt, L., Heinemann, L., Hess, G., Kubiak, T., Küstner, E., Priesterroth, L., Stahl, C., Holl, R. W., et al. (2023) · Diabetic Medicine · doi:10.1111/dme.15261 · Cited by 22
Foresta, A., Succurro, E., Baviera, M., Macaluso, G., Fernandez, M. L. O., Roncaglioni, M. C., Fortino, I., Nobili, A., & Sesti, G. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110742 · Cited by 20
Russo, V., D’Aquino, M. M. C., Caturano, A., Scognamiglio, G., Pezzullo, E., Fabiani, D., Giudice, C. D., Carbone, A., Bottino, R., Caso, V. M., et al. (2023) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001450 · Cited by 20
de Oliveira, R. E. M., Icuma, T. R., Ueta, J. M., & Franco, L. J. (2021) · Ciência & Saúde Coletiva · doi:10.1590/1413-812320212611.3.03752020 · Cited by 19
Oktora, M. P., Yuniar, C. T., Amalia, L., Abdulah, R., Hak, E., & Denig, P. (2023) · BMC Geriatrics · doi:10.1186/s12877-022-03718-9 · Cited by 20
Medication Prescribing for Type 2 Diabetes in the US Long-Term Care Setting: Observational Study
Pandya, N., Jung, M., Norfolk, A., Goldblatt, C. M., Trenery, A., & Sieradzan, R. (2023) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2023.03.020 · Cited by 19
Thaenpramun, R., Komolsuradej, N., Buathong, N., & Srikrajang, S. (2024) · British Journal Of Nutrition · doi:10.1017/s0007114524000175 · Cited by 19
Nie, K., Gao, Y., Wang, H., Su, H., Shen, C., Jiang, X., Dong, H., & Tang, Y. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155954 · Cited by 20
Niznik, J. D., Zhao, X., Slieanu, F., Mor, M. K., Aspinall, S. L., Gellad, W. F., Ersek, M. T., Hickson, R. P., Springer, S. P., Schleiden, L. J., et al. (2022) · Diabetes Care · doi:10.2337/dc21-2116 · Cited by 19
Care Coordination of Older Adults With Diabetes: A Scoping Review
Northwood, M., Shah, A. Q., Abeygunawardena, C., Garnett, A., & Schumacher, C. (2022) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2022.11.004 · Cited by 19
Transitions in Frailty and 4-Year Mortality Risk in Taiwan Longitudinal Study on Aging
Hwang, A., Chen, L., Tang, T.-C., Peng, L.-N., Lin, M., Chou, Y., Hsiao, F., & Chen, L. (2022) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2022.10.005 · Cited by 17
Miyazawa, I., Yokoyama, H., Yagi, N., Araki, S., Morino, K., Kume, S., Shirabe, S., Yamazaki, K., & Maegawa, H. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110599 · Cited by 17
Equity in the Provision of Diabetes Self-Management Education and Support
Blanchette, J. E., Aaron, S., Allen, N. A., & Litchman, M. L. (2022) · Diabetes Spectrum · doi:10.2337/dsi22-0005 · Cited by 20
Abdelhafiz, A. H., Keegan, G. L., & Sinclair, A. J. (2023) · Metabolites · doi:10.3390/metabo13060705 · Cited by 16
Qin, Y.-N., & Zheng, X. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01165-z · Cited by 16
Jaloli, M., & Cescon, M. (2023) · Control Engineering Practice · doi:10.1016/j.conengprac.2023.105762 · Cited by 16
Use of continuous glucose monitoring in insulin-treated older adults with type 2 diabetes
Leite, S. A. O., da Silva, M. P., Lavalle, A. C. R., Bertogy, M. C. V., Bastos, M., Kuklik, S. C. V., & Umpierrez, G. E. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01225-4 · Cited by 17
Butt, S. A., Naseer, M., Ali, A., Khalid, A., Jamal, T., & Naz, S. (2024) · Engineering Applications of Artificial Intelligence · doi:10.1016/j.engappai.2024.108233 · Cited by 16
Changes in Type 2 Diabetes Medication Utilization and Costs in the United States, 2014–2019
Neilson, L. M., Munshi, K. D., Peasah, S. K., Huang, Y., Swart, E. C. S., Henderson, R. R., Manolis, C. H., & Good, C. B. (2021) · Medical Care · doi:10.1097/mlr.0000000000001597 · Cited by 17
First real-world experience with bigfoot unity: a 6-month retrospective analysis
Baliga, B. S., Tillman, J. B., Olson, B., Vaughan, S., Sheikh, F. N., & Malone, J. K. (2023) · Clinical Diabetes · doi:10.2337/cd22-0126 · Cited by 15
Kosjerina, V., Carstensen, B., Jørgensen, M. E., Brock, B., Christensen, H. R., Rungby, J., & Andersen, G. S. (2021) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(21)00170-7 · Cited by 15
Lajara, R., Heller, C. G., Pantalone, K. M., Lew, E., Li, X., DEX, T. A., & Kilpatrick, C. R. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14974 · Cited by 15
Dai, H., Radwan, R. M., Scheiffele, G. D., Tang, H., Sheer, A., Lin, H., Zhang, P., Adirika, D., Luong, K., Bian, J., et al. (2025) · Obesity · doi:10.1002/oby.70024 · Cited by 15
Type 1 diabetes and frailty: A scoping review
Golding, J. A., Yong, E. S. T., Hope, S. V., Wright, J. E., Levett, T. J., & Chakera, A. J. (2024) · Diabetic Medicine · doi:10.1111/dme.15344 · Cited by 15
Blood pressure targets for hypertension in patients with type 2 diabetes
Aronow, W. S., & Shamliyan, T. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.04.36 · Cited by 15
Sabán-Ruiz, J., & Ly-Pen, D. (2020) · The journal of nutrition health & aging · doi:10.1007/s12603-020-1385-5 · Cited by 14
Trawley, S. L., Ward, G. M., Vogrin, S., Colman, P. G., Fourlanos, S., Grills, C. A., Lee, M. H., MacIsaac, R. J., Alipoor, A. M., O'Neal, D. N., et al. (2022) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(22)00266-5 · Cited by 14
Thorpe, C. T., Niznik, J. D., & Li, A. (2023) · BMC Geriatrics · doi:10.1186/s12877-023-04194-5 · Cited by 14
Aggarwal, P., Sinha, S. K., Khanra, D., Nath, R. K., Gujral, J. S., Reddy, N. V., & Mukherjee, A. (2021) · Indian Heart Journal · doi:10.1016/j.ihj.2021.01.016 · Cited by 13
Hypoglycemia in type 2 diabetes
LeBras, M. H., & Laubscher, T. A. (2021) · Canadian Family Physician · doi:10.46747/cfp.670135 · Cited by 12
Prázný, M., Суплотова, Л. А., Gumprecht, J., Kamenov, Z. A., Fülöp, T., Medvedchikov, A., Rosenzweig, D., & Aleksandric, M. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01631-4 · Cited by 12
Wu, C., Wang, C., Saskin, R., Shah, B. R., Kapral, M. K., Lanctôt, K. L., Herrmann, N., Cogo‐Moreira, H., MacIntosh, B. J., Edwards, J. D., et al. (2023) · Journal of Internal Medicine · doi:10.1111/joim.13723 · Cited by 12
Denig, P., & Stuijt, P. J. C. (2024) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2024.2378765 · Cited by 12
Metadata
- Authors
- American Diabetes Association Professional Practice Committee
- Corresponding author
- American Diabetes Association Professional Practice Committee
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2021-12-16
- Volume
- 45
- Issue
- Supplement_1
- Pages
- S195-S207
- ISSN
- 0149-5992 (ISSN-L)
- PMC
- PMC8935395
- OpenAlex
- W4200063208
- Cited by
- 381
- References
- 116
- Citations by year
- 2026: 13 · 2025: 34 · 2024: 68 · 2023: 115 · 2022: 86 · 2021: 26
- FWCI
- 11.31
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (K24AG069080, R01AG060756, R01AG063391)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK092949)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- diabetes in older adults, clinical guidelines, treatment goals, quality of care, level of evidence
- MeSH terms
- Aged, Diabetes Mellitus, Endocrinology, Humans, Reference Standards, Societies, Medical, Standard of Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
